Additional file 1:Â Formula S1. The formal structural formula of the hydrogen bonds. Figure S1. Ex vivo fluorescence intensity of brains and normal organs harvested from nude mice intravenously treated with the OEA-Cy 5.5 or OEA(-Cy 5.5)-SPC NPs at 24Â h post-injection. Figure S2. Iba-1+ cells in cortex. Figure S3. Quantitative analysis of Iba-1+ cells in cortex. Figure S4. Iba-1+ cells hippocampal CA1. Figure S5. Quantitative analysis of Iba-1+ cells hippocampal CA1
Additional file 1: Fig. S1 Experimental designs in animal models. (A) The study design of the expres...
Figure S4. In vivo efficacy of candidate compounds on H1_DL2 brain metastases. a Left panel: Tumor c...
Figure S1. Metabolism of 51657. Figure S2. ADR-Res cells expressing Pgp are more sensitive to 51657 ...
Additional file 3: Figure S3. Cy5.5-AuNPs in intra parenchymal injected mice. Panel A shows FLI anal...
Additional file 1: Figure S1. Chemical structures and synthetic route of hyaluronic acid-cysteamine ...
Additional file 1: Fig.S1. CAL-33 tumor model in CD1-Foxn1 nu nude mice. Tumor growth after injectio...
Supplementary Material 1: Figure S1. Percentages and MFIs of DiO-labeled MLNPs internalized by L929 ...
Viability of microglial cells exposed to DHA treatment. A–B. Viability of N9 microglial cells in res...
Iba-1 immunoreactivity (Iba-1-ir) is shown in the m-PFC of sham or SNI mice (30 days after injury) f...
Additional file 1: Figure S1. The 1H-NMR spectra of (A) CS, (B) PLGA, and (C) CS-PLGA. Figure S2. Ze...
Additional file 1: Figure S1. Fourier-Transform infrared spectra of Porphyra yezoensis polysaccharid...
Additional file 1: Figure S1. UV/Vis spectra of “bare” NPs (Au@tiopronin) before the modification, a...
Additional file 1: Figure S1. Estimation of the number of c(RGDyK) peptide, Cy5.5, or miR-210 incorp...
Additional file 1: Table S1. Information on induced pluripotent stem cell (iPSC) lines used in study...
Figure S1. Visualization of MCHB generation in living mice by fluorescence imaging. Following CNOB a...
Additional file 1: Fig. S1 Experimental designs in animal models. (A) The study design of the expres...
Figure S4. In vivo efficacy of candidate compounds on H1_DL2 brain metastases. a Left panel: Tumor c...
Figure S1. Metabolism of 51657. Figure S2. ADR-Res cells expressing Pgp are more sensitive to 51657 ...
Additional file 3: Figure S3. Cy5.5-AuNPs in intra parenchymal injected mice. Panel A shows FLI anal...
Additional file 1: Figure S1. Chemical structures and synthetic route of hyaluronic acid-cysteamine ...
Additional file 1: Fig.S1. CAL-33 tumor model in CD1-Foxn1 nu nude mice. Tumor growth after injectio...
Supplementary Material 1: Figure S1. Percentages and MFIs of DiO-labeled MLNPs internalized by L929 ...
Viability of microglial cells exposed to DHA treatment. A–B. Viability of N9 microglial cells in res...
Iba-1 immunoreactivity (Iba-1-ir) is shown in the m-PFC of sham or SNI mice (30 days after injury) f...
Additional file 1: Figure S1. The 1H-NMR spectra of (A) CS, (B) PLGA, and (C) CS-PLGA. Figure S2. Ze...
Additional file 1: Figure S1. Fourier-Transform infrared spectra of Porphyra yezoensis polysaccharid...
Additional file 1: Figure S1. UV/Vis spectra of “bare” NPs (Au@tiopronin) before the modification, a...
Additional file 1: Figure S1. Estimation of the number of c(RGDyK) peptide, Cy5.5, or miR-210 incorp...
Additional file 1: Table S1. Information on induced pluripotent stem cell (iPSC) lines used in study...
Figure S1. Visualization of MCHB generation in living mice by fluorescence imaging. Following CNOB a...
Additional file 1: Fig. S1 Experimental designs in animal models. (A) The study design of the expres...
Figure S4. In vivo efficacy of candidate compounds on H1_DL2 brain metastases. a Left panel: Tumor c...
Figure S1. Metabolism of 51657. Figure S2. ADR-Res cells expressing Pgp are more sensitive to 51657 ...